Hana Securities lowered its Samsung Biologics price target from 2.03 million won to 1.95 million won

Statements (2)

1. ▼ Bearish

   Daol Investment Securities lowered its Samsung Biologics price target from 2.1 million won to 2.0 million won

   yna.co.krOct 5, 2026 23:29 UTC
2. ▼ Bearish

   Hana Securities lowered its Samsung Biologics price target from 2.03 million won to 1.95 million won

   mk.co.krOct 5, 2026 22:55 UTC